Back

Esperite N.V.

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 06 nov 2018 - 08:55
  • Statutory name Esperite N.V.
  • Title Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication : Bronchopulmonary Dysplasia

Related downloads

201811060000000006_Esperite Group with The Cell Factory expands its Extracellular Vesicles product portfolio of anti-inflammatory drugs with a fourth indication Bronchopulmonary Dysplasia.pdf

Date last update: 18 December 2018

Share information

Share on: Share this